
Guardians at trade deadline: Teams want Emmanuel Clase, Shane Bieber, but will Cleveland sell?
'I think we have a good team right here. We believe in a lot of the guys we have. We're starting to see signs of the offense coming to life, which is really what's been missing all year. So, we're as confident as we've been in this team, and the pitching is still doing a phenomenal job. We just have to be open-minded to different ways to make our team better.'
Advertisement
No, that wasn't a Cleveland executive describing the Guardians' state of affairs. It was J.J. Picollo, the Royals' president of baseball operations, though it sounded like he was reading off a Chris Antonetti cue card.
The Guardians and Royals are in similar positions. So, too, are the Minnesota Twins, Texas Rangers, Tampa Bay Rays, St. Louis Cardinals, Cincinnati Reds and San Francisco Giants. They're all hanging around the wild-card chase and have to determine by Thursday evening whether they want to bolster their chances, shift their focus to 2026 or stand pat. Having three wild-card berths in each league not only keeps more teams in the mix but also stifles and complicates trade activity.
So, how do teams like the Guardians approach this week? Well, it started with surveying their fellow front offices in early July to get a sense of who might become available later in the month. Then, they diverted their attention to the draft for a few days. Now, the trade conversations, in all forms, have resumed and gained steam. The Guardians, figuring a more inviting part of the schedule could fuel a pre-deadline surge, prepared themselves so that no matter their ultimate path forward — buying, selling, both, neither — they had done the legwork on each approach.
It's why Picollo, for instance, wouldn't classify the Royals as strictly buyers or sellers but instead said, 'We're in the business of getting better,' noting that could mean in 2025 or the future. The Royals have added two position players in recent days: second baseman Adam Frazier and outfielder Randal Grichuk. Neither veteran is going to transform what's been a lackluster lineup, but it surely signals — along with extending pitcher Seth Lugo — a more aggressive approach than the Guardians have exhibited, despite a similarly deficient offense and a nearly identical record. Aside from perhaps prospect C.J. Kayfus, no internal reinforcements for Cleveland's lineup are on the way, thanks to injuries to Chase DeLauter, Juan Brito and Lane Thomas. If the Guardians want to stay in the race, they'll need an outside addition or two to their lineup.
Advertisement
The Guardians weathered a 10-game skid and have since won 12 of 17. Meanwhile, the Detroit Tigers are in a free fall. They once led Cleveland by 15 1/2 games in the AL Central. Now it's eight, and the soft patch in the Guardians' schedule reaches a crescendo this week as they welcome the dreadful Colorado Rockies to Progressive Field.
A fascinating (or boring — it could definitely wind up being boring) few days lie ahead.
As Cleveland closer Emmanuel Clase retreated to the visitors dugout Saturday afternoon, he attempted a frustration-filled kick of Jonathan India's blue helmet, which had rolled away from the Royals' celebration at home plate after his walk-off home run. Clase whiffed on the boot (probably for the best). It was the first walk-off homer he has surrendered since July 16, 2021.
He wasn't thrilled with the strike zone in the 10th inning of the first game of the doubleheader. He urged manager Stephen Vogt to let him pitch in the nightcap, and he sealed a Guardians win.
Clase is the most prolific closer in franchise history, and despite the India homer, he has resurrected a season that started miserably. Before Saturday, he had logged a 1.10 ERA since May 1. He has three more seasons of team control remaining after 2025, and at less than $30 million total.
As far as relievers go, Clase has a bunch of value and a lot of teams calling — all the contenders you'd expect. Clase has heard the chatter and says he doesn't give it much thought.
The Guardians tend to move on from pitchers before it's too late — that's how they acquired Clase in the first place, for Corey Kluber in December 2019 — but they certainly don't have to trade Clase this week. That's the message to other teams, too. The Guardians have scouts checking in on prospects for some of the legitimate contenders, due diligence that every team conducts this time of year. (For what it's worth, there's been a throng of pro scouts following the club the last couple of weeks, too, especially with the team playing the Baltimore Orioles, a certain seller, and the Royals, a team in the middle.)
Advertisement
Is there an offer for Clase that wouldn't exist this winter? For the Guardians to hang around in the race, don't they need Clase, since their lineup isn't going to receive an extreme makeover? These are the debates taking place in the offices at 2401 Ontario St. He sits atop the list of potentially available relievers, though, and there's a long line of teams interested. The Philadelphia Phillies, New York Mets, Chicago Cubs, Los Angeles Dodgers, New York Yankees, Toronto Blue Jays and Tigers all want bullpen help.
As one teammate put it: 'No reliever is safe on planet Earth. Not even (Clase), which is crazy. But every team wants him. When you get to the postseason, you need more relievers. No (team) is sitting here today being like, 'I think we're good with the relievers we have.' That's what makes it interesting.'
On July 29, 2023, the Guardians sat at 52-53, 1 1/2 games out of a playoff spot.
On July 28, 2025, the Guardians sit at 52-53, 3 1/2 games out of a playoff spot.
Cleveland's decision to sell in 2023 came pretty late and was fueled, in part, by the notion that it would never be able to obtain more for Aaron Civale than it could at that moment, when it landed Kyle Manzardo from the Rays. Civale's value had peaked. He has been traded twice since and could be dealt a third time in the next few days. Rays execs even acknowledged to members of the Guardians front office at the time that it wasn't the Rays' typical mode of operation. Manzardo was a top 100 prospect, and the Rays drool over future value. But they had first-base depth and needed a win-now move to help their rotation.
This year, the Guardians' selling options fall into three categories.
In addition to Clase, teams have called about Steven Kwan. He's the exact player the Phillies desire in left field. For the Guardians, it's the same thought process they have with Clase. Is it something they need to do right now, or can they revisit it this winter, especially if long-term extension talks continue to hit a dead end?
Advertisement
Cade Smith falls into this group, too, but it's almost impossible to envision the Guardians trading him when he has 4 1/2 years of team control remaining and could be the heir apparent to Clase.
Carlos Santana's punchless bat — and at 39 years old, that shouldn't be a shocking development — has sapped him of his value, at least at the plate. He remains a skilled defender, but teams aren't exactly lining up for glove-first first basemen this time of year. He likely ranks behind Baltimore's Ryan O'Hearn and, if the Rays make him available, Yandy Díaz in the first-base pecking order. Santana did not crack The Athletic's big board of the top 50 trade candidates.
The Seattle Mariners, who tried to sign Santana last winter, opted to deal this week for Josh Naylor, whom Santana replaced in Cleveland.
'Any moment that a team shows interest in you and the product that you bring,' Bo Naylor said of his talk with his brother about the trade, 'and the type of player you are, that's always something to be excited about.'
If the Guardians move Santana, they could promote Kayfus from Triple-A Columbus to share first-base/DH duties with Manzardo and David Fry. If Fry could play first base at some point in the final two months — he's throwing out to 90 feet, and one coach said his arm looks great — that would give the front office even more motivation to part with Santana. Vogt, though, sprinkled some doubt on Fry's playing in the field in 2025 and said the focus is for him to catch in 2026.
Lane Thomas, another impending free agent, would have been a trade candidate, but his foot has not cooperated. He's likely out until September because of a lingering case of plantar fasciitis. This contract year has been an abject nightmare for him.
Paul Sewald, who has a $10 million club option for next year that almost certainly will not be exercised, is on the shelf with a strain in the back of his shoulder. He said himself that it probably eliminates him from trade consideration.
And then there's the curious case of Shane Bieber.
He logged three innings at Class-A Lake County on Tuesday, but his start Sunday for Triple-A Columbus was rained out. If the Guardians want to move him, there's a market.
He's earning $10 million this year and has a $4 million buyout or a $16 million player option for next season. Barring a significant setback, it's difficult to envision him exercising that option, so he should hit free agency this winter.
Advertisement
The Guardians have received calls on Bieber, and they know all about midseason acquisitions of pitchers recovering from injury. They signed Matthew Boyd and traded for Alex Cobb last summer to rescue their rotation.
The starting pitching market is lacking in sizzle — that is, unless the AL Central reshapes the market. Even with Lugo off the board, Bieber and Minnesota's Joe Ryan would be two of the top names on the market.
For Cleveland to move Bieber, it would need to acquire a prospect with more potential than whoever it could select with the draft pick it would recoup if Bieber departs in free agency. If the Guardians hold on to him and he opts out, they can submit a qualifying offer (which last year was worth about $21 million for one year). If Bieber rejects that and signs elsewhere for at least $50 million, the Guardians would be awarded a compensatory pick after the first round. If he signs elsewhere for less than $50 million, the Guardians would be awarded a compensatory pick after the second round.
If his rescheduled outing takes place Tuesday in Akron, the staff at Canal Park might want to clear some extra seats for scouts.
(Top photo of Emmanuel Clase: Nick Cammett / Getty Images)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
NHC Reports Second Quarter 2025 Earnings
MURFREESBORO, Tenn., August 08, 2025--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended June 30, 2025 totaled $374,910,000 compared to $300,658,000 for the quarter ended June 30, 2024, an increase of 24.7%. The increase in net operating revenues for the second quarter of 2025 compared to the second quarter of 2024 was due to an 9.6% increase in same-facility net operating revenues, as well as the August 1, 2024 acquisition of White Oak Management, Inc. ("White Oak"). For the quarter ended June 30, 2025, the reported GAAP net income attributable to NHC was $23,722,000 compared to $26,844,000 for the same period in 2024. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended June 30, 2025 was $25,710,000 compared to $15,612,000 for the same period in 2024, an increase of 64.7% (*). The GAAP diluted earnings per share were $1.52 and $1.73 for the quarters ending June 30, 2025 and 2024, respectively. Adjusted diluted earnings per share were $1.65 and $1.00 for the quarters ending June 30, 2025 and 2024, respectively (*). (*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items. About NHCAs of August 1, 2025, NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,329 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. NHC's other services include Alzheimer's and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at Non-GAAP Financial PresentationThe Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Forward-Looking StatementsStatements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC's best judgment as of the date of this release. Consolidated Statements of Operations (in thousands, except share and per share amounts) Three Months Ended Six Months Ended June 30 June 30 2025 2024 2025 2024 (unaudited) (unaudited) Revenues: Net patient revenues $ 363,349 $ 279,918 $ 724,956 $ 565,741 Other revenues 11,561 11,295 23,651 22,648 Government stimulus income - 9,445 - 9,445 Net operating revenues and grant income 374,910 300,658 748,607 597,834 Costs and expenses: Salaries, wages and benefits 226,534 180,076 454,664 363,214 Other operating 91,943 78,154 184,400 155,583 Facility rent 11,328 10,570 22,693 20,918 Depreciation and amortization 11,015 9,338 21,993 19,924 Total costs and expenses 340,820 278,138 683,750 559,639 Income from operations 34,090 22,520 64,857 38,195 Non-operating income 5,132 4,956 9,211 10,641 Interest expense (1,993 ) - (4,099 ) (46 ) Unrealized gains/(losses) on marketable equity securities (5,061 ) 9,124 5,921 23,523 Income before income taxes 32,168 36,600 75,890 72,313 Income tax provision (8,055 ) (9,494 ) (19,487 ) (18,956 ) Net income 24,113 27,106 56,403 53,357 Net income attributable to noncontrolling interest (391 ) (262 ) (476 ) (300 ) Net income attributable to National HealthCare Corporation $ 23,722 $ 26,844 $ 55,927 $ 53,057 Net income per common share Basic $ 1.53 $ 1.74 $ 3.62 $ 3.45 Diluted $ 1.52 $ 1.73 $ 3.59 $ 3.42 Weighted average common shares outstanding Basic 15,462,135 15,391,535 15,450,286 15,371,150 Diluted 15,599,638 15,555,612 15,587,783 15,530,624 Dividends declared per common share $ 0.64 $ 0.61 $ 1.25 $ 1.20 Balance Sheet Data June 30 December 31 (in thousands) 2025 2024 (unaudited) Cash, cash equivalents and marketable securities $ 257,628 $ 216,185 Restricted cash, cash equivalents and marketable securities 169,340 163,795 Current assets 463,227 424,408 Property and equipment, net 676,619 684,289 Total assets 1,562,220 1,524,429 Current liabilities, excluding current long-term debt 261,245 227,297 Current and long-term debt 110,000 137,000 NHC stockholders' equity 1,021,905 980,161 Selected Operating Statistics Three Months Ended Six Months Ended June 30 June 30 2025 2024 2025 2024 (unaudited) (unaudited) Skilled Nursing Per Diems: Medicare $ 614.85 $ 577.71 $ 613.47 $ 579.81 Managed Care 486.17 447.96 489.30 459.48 Medicaid 286.43 264.49 284.07 264.88 Private Pay and Other 341.34 312.91 339.24 310.31 Average Skilled Nursing Per Diem $ 361.42 $ 338.86 $ 360.78 (1) $ 341.21 (1) Skilled Nursing Patient Days: Medicare 83,615 74,602 169,869 155,758 Managed Care 83,015 62,957 166,661 128,388 Medicaid 368,687 279,504 732,329 561,325 Private Pay and Other 194,202 150,234 378,796 307,677 Total Skilled Nursing Patient Days 729,519 567,297 1,447,655 (1) 1,153,148 (1) (1) NHC exited three skilled nursing facilities in Missouri on March 1, 2024. For the six months ended June 30, 2024, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $275.64 and 20,267 patient days. The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): Three Months Ended Six Months Ended June 30 June 30 2025 2024 2025 2024 (unaudited) (unaudited) Net income attributable to National Healthcare Corporation $ 23,722 $ 26,844 $ 55,927 $ 53,057 Non-GAAP adjustments Unrealized (gains)/losses on marketable equity securities 5,061 (9,124 ) (5,921 ) (23,523 ) Operating losses for newly-opened operations not at full capacity - 20 - 20 Gain on sale of property and equipment (3,606 ) - (3,606 ) - Gain on sale of unconsolidated company - - - (1,024 ) Stock-based compensation expense 1,232 1,176 2,260 1,969 Acquisition-related expenses - 2,194 - 2,194 Employee retention credit - (9,445 ) - (9,445 ) Income tax provision/(benefit) on non-GAAP adjustments (699 ) 3,947 1,889 7,750 Non-GAAP Net income $ 25,710 $ 15,612 $ 50,549 $ 30,998 GAAP diluted earnings per share $ 1.52 $ 1.73 $ 3.59 $ 3.42 Non-GAAP adjustments Unrealized (gains)/losses on marketable equity securities 0.32 (0.59 ) (0.38 ) (1.51 ) Gain on sale of property and equipment (0.23 ) - (0.23 ) - Gain on sale of unconsolidated company - - - (0.07 ) Stock-based compensation expense 0.08 0.08 0.14 0.13 Acquisition-related expenses - 0.14 - 0.14 Employee retention credit - (0.61 ) - (0.61 ) Income tax provision/(benefit) on non-GAAP adjustments (0.04 ) 0.25 0.12 0.50 Non-GAAP diluted earnings per share $ 1.65 $ 1.00 $ 3.24 $ 2.00 View source version on Contacts Brian F. Kidd, SVP/CFOPhone: (615) 890-2020
Yahoo
21 minutes ago
- Yahoo
Under Armour forecasts downbeat quarterly sales, shares drop
(Reuters) -Under Armour forecast second-quarter revenue below estimates on Friday as the sportswear maker grapples with muted demand in North America due to still-high inflation and tariff uncertainty, sending its shares down 14% in premarket trading. The Maryland-based retailer's attempts to reset its business after sales declined over the last two years have been in jeopardy, with consumer spending weakening in the U.S. as the Trump administration's fluctuating tariff policies fan uncertainty. Under Armour in May announced plans to raise prices, risking demand for its apparel as customers look for cheaper options. On Friday, the company said the forecast includes considerations for ongoing uncertainty around trade policies and the broader macroeconomic environment, including potential demand and cost impacts from tariffs. The company now expects quarterly revenue to decline between 6% and 7%, compared with analysts' average estimate of a 2.9% drop, according to data compiled by LSEG.
Yahoo
21 minutes ago
- Yahoo
How Much Is Joe Biden's Social Security Check?
If you've ever wondered if former presidents and senators are eligible for Social Security, the answer is yes. Just as every other American who earns pays into Social Security Insurance through taxes, when they reach retirement age, they are eligible to draw benefits. Discover More: Find Out: And after 36 years as a senator, eight years as vice president and four years as president, Joe Biden is not only eligible, but collecting Social Security benefits. In fact, he's collecting well above the average Social Security recipient. How Much Is Joe Biden's Monthly Social Security Check? Unlike President Donald Trump, Joe Biden has released his annual tax returns since 1998. His 2024 return is not released yet, but his 2023 joint federal tax return, with his wife Dr. Jill Biden, states that he received $42,842 in Social Security income. That works out to approximately $3,570 per month. His wife received $21,412 in Social Security for the year of 2023. That works out to about $1,784 per month. The fact that this amount is almost exactly half of Joe Biden's suggests that she is likely drawing spousal benefits since those are capped at 50%, according to the Social Security Administration. Learn More: How Much Did Joe Biden Make as a Politician? You may be wondering why Joe Biden's Social Security is so high. The simple answer is that as a U.S. senator he drew a pretty good salary by most people's standards. Therefore, he paid and earned a high Social Security rate. Biden was elected to the U.S. Senate in 1972, when senators made $42,500 per year, according to the U.S. Senate website. That's more than $333,000 in today's dollars. Over the next few decades, his salary as senator gradually increased to $89,500 in 1987. He then ran for president and lost, but became a senator again from 1990 to 2007, finishing with a salary of $165,200. He then, of course became vice president and president. Biden first began receiving Social Security benefits in 2008 ($6,534) and in full in 2009 ($27,923). What Is the Average Social Security Check Amount? If you're wondering where Biden stands in relation to other Americans drawing Social Security benefits, he's above average. According to the Social Security Administration's (SSA) Monthly Statistical Snapshot, for the month of June 2025, the average benefit for retired workers was $2,005.05. More From GOBankingRates 5 Old Navy Items Retirees Need To Buy Ahead of Fall Mark Cuban Tells Americans To Stock Up on Consumables as Trump's Tariffs Hit -- Here's What To Buy This article originally appeared on How Much Is Joe Biden's Social Security Check?